These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15025892)

  • 1. Recommendations regarding definitions and standards in healing research.
    Jonas WB; Chez RA
    J Altern Complement Med; 2004 Feb; 10(1):171-81. PubMed ID: 15025892
    [No Abstract]   [Full Text] [Related]  

  • 2. New report calls for comprehensive, evidence-based CAM.
    Adv Mind Body Med; 2005; 21(1):33. PubMed ID: 15973857
    [No Abstract]   [Full Text] [Related]  

  • 3. David Moher, MSc The CONSORT Guidelines: improving the quality of research. Consolidated Standards of Reporting Trials. Interview by Bonnie Horrigan.
    Moher D
    Altern Ther Health Med; 2002; 8(3):103-8. PubMed ID: 12017485
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical models. Cultural, historical and terminology issues.
    Cassidy CM
    J Altern Complement Med; 2004 Apr; 10(2):401-3. PubMed ID: 15165423
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary on terminology and therapeutic principles: challenges in classifying complementary and alternative medicine practices.
    Cassidy CM
    J Altern Complement Med; 2002 Dec; 8(6):893-5. PubMed ID: 12619650
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrating qualitative methods in randomized controlled trials: the experience of the Oregon Center for Complementary and Alternative Medicine.
    Vuckovic N
    J Altern Complement Med; 2002 Jun; 8(3):225-7. PubMed ID: 12165180
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole systems research: a discipline for studying complementary and alternative medicine.
    Ritenbaugh C; Verhoef M; Fleishman S; Boon H; Leis A
    Altern Ther Health Med; 2003; 9(4):32-6. PubMed ID: 12868250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological changes in the evaluation of complementary and alternative medicine: issues raised by Sherman et al. and Hawk et al.
    Redwood D
    J Altern Complement Med; 2002 Feb; 8(1):5-6. PubMed ID: 11890434
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy, effectiveness, pragmatic trials--guidance on terminology and the advantages of pragmatic trials.
    Witt CM
    Forsch Komplementmed; 2009 Oct; 16(5):292-4. PubMed ID: 19887807
    [No Abstract]   [Full Text] [Related]  

  • 10. Science and government. Enhanced: in defense of NCCAM.
    Straus SE; Chesney MA
    Science; 2006 Jul; 313(5785):303-4. PubMed ID: 16857924
    [No Abstract]   [Full Text] [Related]  

  • 11. The science of the placebo: toward an interdisciplinary and research agenda, November 2000.
    Wade CM; Jacobson JS; Mindes J; Coleton MI
    J Altern Complement Med; 2001 Aug; 7(4):383-7. PubMed ID: 11558781
    [No Abstract]   [Full Text] [Related]  

  • 12. Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.
    Hoffer LJ
    CMAJ; 2001 Feb; 164(3):351-3. PubMed ID: 11232135
    [No Abstract]   [Full Text] [Related]  

  • 13. World hypotheses and the evolution of integrative medicine: combining categorical diagnoses and cause-effect interventions with whole systems research and nonvisualizable (seemingly "impossible") healing.
    Schwartz GE; Schloss EP
    Explore (NY); 2006; 2(6):509-14. PubMed ID: 17113491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine in outcomes research.
    Riley D; Berman B
    Altern Ther Health Med; 2002; 8(3):36-7. PubMed ID: 12017498
    [No Abstract]   [Full Text] [Related]  

  • 16. Intangible principles of good research in complementary and alternative medicine.
    Ernst E
    Altern Ther Health Med; 2002; 8(3):22. PubMed ID: 12017495
    [No Abstract]   [Full Text] [Related]  

  • 17. Research on the treatment of trauma spectrum responses: the role of the optimal healing environment and neurobiology.
    Osuch E; Engel CC
    J Altern Complement Med; 2004; 10 Suppl 1():S211-21. PubMed ID: 15630838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief evidence-based review of two gastrointestinal illnesses: irritable bowel and leaky gut syndrome.
    Manahan B
    Altern Ther Health Med; 2004; 10(4):14. PubMed ID: 15285270
    [No Abstract]   [Full Text] [Related]  

  • 19. NCCAM: a new plan, new priorities, and an open invitation.
    Straus SE; Chesney MA
    Altern Ther Health Med; 2004; 10(6):16. PubMed ID: 15624345
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials in cancer part II. Biomedical, complementary, and alternative medicine: significant issues.
    Lee CO
    Clin J Oncol Nurs; 2004 Dec; 8(6):670-4. PubMed ID: 15637963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.